NCT01291537已完成2 期
Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 56
- 试验地点
- 20
研究概览
简要总结
The goal of this multicentric prospective randomized controlled clinical and economic study is to investigate the effectiveness and cost-utility of long-term continuous intraduodenal infusion of levodopa ( DUODOPA), compared to best medical treatment, on advanced and severe form of Parkinson's disease.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •Age <18 and> 80 years
- •No signature of the informed consent form
- •Patient with no social insurance or who cannot benefit it through a third person in accordance with the French law on biomedical research
- •Population under enhanced protection (i.e minors), pregnant women, breast-feeding women, persons deprived of their liberty by a judicial or administrative decision, people in health and social service, adults under legal protection, and finally patients in emergency situations.
研究组 & 干预措施
Duodopa
Experimental
干预措施: Duodopa (Drug)
Best medical treatment
Active Comparator
干预措施: best médical treatment (Drug)
研究者
研究点 (20)
Loading locations...
相似试验
已完成
不适用
Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's DiseaseParkinson's DiseaseNCT02906488AbbVie839
已完成
4 期
Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefitParkinson DiseaseNCT00272688University Hospital, Akershus10
已完成
不适用
Observational Study to Evaluate PAD Treatment Clinical and Economic OutcomesPeripheral Arterial Occlusive DiseaseNCT01855412Abbott Medical Devices1,204
已完成
3 期
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's SubjectsAdvanced Parkinson's DiseaseNCT00357994AbbVie (prior sponsor, Abbott)36
已完成
3 期
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's SubjectsAdvanced Parkinson's DiseaseNCT00660387AbbVie (prior sponsor, Abbott)35